IOTOX Algorithm vs ATA 2026

Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. ​​​​​​​ Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.

The American Thyroid Association is the leading organization focused on thyroid biology and the prevention and treatment of thyroid disorders through excellence and innovation in research, clinical care, education, and public health. Earn CME credits, hear innovative talks on clinical topics, participate in interactive sessions, develop professionally with state-of-the-art information, and meet with friends and colleagues.